WASHINGTON, DC – MedStar Cardiovascular Research Network announced that the first patient who underwent transcatheter aortic valve replacement (TAVR) with the Lotus EdgeTM Aortic Valve System (Boston Scientific, Marlborough, MA) as part of the Low Risk TAVR (LRT) trial was successfully discharged from MedStar Washington Hospital Center the day after the procedure.